Details of the Drug
General Information of Drug (ID: DMT81N3)
Drug Name |
1-(4-(benzyloxy)phenyl)propan-2-amine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-Benzyloxyamphetamine; 1-(4-phenylmethoxyphenyl)propan-2-amine; CHEMBL456013; 7176-39-8; ZDZASCUBDMUTSR-UHFFFAOYSA-N; p-benzyloxyamphetamine; 1-(4-(benzyloxy)phenyl)propan-2-amine; Phenethylamine, p-(benzyloxy)-alpha-methyl-; alpha-Methyl-4-(phenylmethoxy)benzeneethanamine; AC1L34WV; Benzeneethanamine, alpha-methyl-4-(phenylmethoxy)-; SCHEMBL2750286; AC1Q56Y9; CTK2H7369; BDBM50276775; AKOS022489255; AKOS000152896; 1-(4-phenylmethoxyphenyl)-2-propanamine; 1-Methyl-2-(4-benzyloxyphenyl)ethanamine
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 241.33 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.5 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 5 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||